No headlines found.
No press releases found.
No news found.
Columbia Research Enhanced Value ETF (the Fund) seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage Research Enhanced U.S. Value Index (the Index). The Beta Advantage Research Enhanced U.S. Value Index (the Index) aims to achieve stronger total return than the Russell 1000 Value Index through a rules-based strategic beta approach. The Index methodology leverages the results of Columbia Threadneedle Investments proprietary equity quantitative investment models to rate each company within the Russell 1000 Value Index based on quality, value and catalyst factors, and selects securities that are favorably rated. It is market cap-weighted and sector-neutral to the Russell 1000 Value Index.
Columbia Research Enhanced Value ETF trades on the ARCA stock market under the symbol REVS.
As of December 29, 2025, REVS stock price declined to $28.53 with 30,538 million shares trading.
REVS has a beta of 0.82, meaning it tends to be less sensitive to market movements. REVS has a correlation of 0.85 to the broad based SPY ETF.
REVS has a market cap of $138.37 million. This is considered a Micro Cap stock.
In the last 3 years, REVS traded as high as $29.39 and as low as $18.79.
REVS has outperformed the market in the last year with a return of +16.3%, while the SPY ETF gained +15.6%. In the last 3 month period, REVS beat the market returning +4.6%, while SPY returned +4.2%. However, in the most recent 2 weeks REVS has underperformed the stock market by returning +0.1%, while SPY returned +1.2%.
REVS support price is $28.42 and resistance is $28.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that REVS shares will trade within this expected range on the day.
